Genome-Wide CRISPR Screen Reveals Autophagy Disruption as the Convergence Mechanism That Regulates the NRF2

Michael J Kerins1, Pengfei Liu1, Wang Tian1

  • 1Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.

Insights

A genome-wide screen identified 273 genes that activate nuclear factor (erythroid 2)-like 2 (NRF2). Eight high-confidence NRF2 negative regulators, including several involved in autophagy, were validated, revealing a link between autophagy and NRF2.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Genetics

Background:

  • Nuclear factor (erythroid 2)-like 2 (NRF2) is a transcription factor crucial for cellular homeostasis.
  • NRF2 deregulation is linked to diseases like cancer and neurodegeneration.
  • A complete regulatory network for NRF2 remains elusive.

Purpose of the Study:

  • To identify novel regulators of NRF2.
  • To elucidate the relationship between NRF2 and other cellular processes.

Main Methods:

  • Genome-wide CRISPR screen to identify NRF2 activators.
  • Pathway analysis to identify enriched biological processes.
  • Molecular validation of candidate NRF2 regulators.

Main Results:

  • A CRISPR screen identified 273 genes whose knockout leads to sustained NRF2 activation.
  • Pathway analysis revealed autophagy-related genes are significantly overrepresented.
  • Eight high-confidence NRF2 negative regulators were validated, including ATG12, ATG7, KEAP1, and VPS37A, which are involved in autophagy.

Conclusions:

  • This study presents a comprehensive list of NRF2 negative regulators.
  • An intimate link between autophagy and NRF2 regulation is revealed.

Related Concept Videos

Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.3K
Transcription Elongation Factors02:35

Transcription Elongation Factors

Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
13.5K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.7K
Master Transcription Regulators02:23

Master Transcription Regulators

2.7K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.2K
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.6K